4D Molecular Therapeutics logo
4D Molecular Therapeutics
FDMT | NASDAQ
Chart Builder DCF Calculator
$11.29
-$0.94 (-7.69%)
At close: Nov 16, 2026, 4:00 PM ET
$11.29
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

4D Molecular Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-78.06M -72.94M -68.76M 19.4M -56.88M -54.66M -47.97M -49.67M -43.84M -34.95M -32.4M -32.28M -10.26M -29.62M -28.68M -27.38M -25.69M -28.09M -26.34M -25.08M -22.24M -7.59M -16.41M
2.01M 2.09M 2.06M 1.98M 2M 1.89M 1.75M 1.78M 1.7M 1.62M 1.59M 1.51M 1.4M 1.43M 1.41M 1.39M 879K 831K 782K 1.89M 760K 742K 381K
8.26M 5.88M 4.45M 5.55M 4.52M 4.96M 6.99M 7.58M 6.49M 6.07M 5.97M 5.91M 4.56M 4.97M 4.22M 4.35M 4.52M 4.32M 3.93M 3.73M 3.92M 3.82M 2.33M
15.03M 480K -8.28M -1.54M 6.84M 1.04M -6.94M -5.18M 8.97M 98K -4.22M 1.75M 1.73M 412K -4.16M -1.87M 720K 2.31M -905K -5.52M 582K -13.37M -2.08M
-1.01M -1.46M -1.12M -1.13M -1.14M -1.15M -1.36M -1.84M -2.2M -2.3M -735K 173K 29K -205K -366K -211K 252K 492K 611K 738K 31K 15K 481K
– – – – – – – – – – – -630K – – – – – – – – – – –
12.09M -3.58M -4.75M 2.76M 5M 5.59M -7.17M -3.72M 8.46M -688K -3.52M 664K 3.1M 1.36M -4.49M -358K -977K 2.54M -2.54M -3.11M 1.8M -13.19M -2.16M
-56.71M -70M -68.13M 28.55M -46.5M -43.38M -47.76M -45.86M -29.39M -30.24M -29.09M -24.65M -1.17M -22.07M -27.91M -22.21M -21.02M -19.9M -23.55M -21.84M -15.72M -16.21M -15.37M
-49K -55K – -631K 91K -66K -631K -949K -1.78M -349K -710K -549K -405K -805K -1.01M -1.09M -1.96M -2.07M -6.41M -5.1M -2.64M -737K -642K
– – 11K – – – – – – – – 49.08M – -50.09M 1.01M – – – – – – – –
-84.83M -62.04M -33.52M -178.1M -15.24M -115.4M -134.08M -57.78M -35.79M -96.76M -277.32M -34.65M – -5.43M -14.73M 100.51M -187.94M -6.19M -59.69M -32.2M -136.38M – –
109.72M 87.65M 102.4M 49.18M 32.93M 101.62M 166.66M 65.79M 64.87M 23.57M 14.78M 28.51M 30.39M 55.52M 58.87M -135.19M 205.28M 65.72M 12M – – – –
– -11K -11K 767K – – – – – – – -49.08M – 50.09M -1.01M – – – – 5M – – –
24.84M 25.54M 68.89M -128.85M 17.78M -13.85M 31.95M 7.06M 27.3M -73.54M -263.26M -6.68M 29.98M 49.29M 43.13M -35.78M 15.37M 57.47M -54.11M -32.29M -139.01M -737K -642K
– 19.26M – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – 567K 1.56M 3.11M 4.76M 1.58M 799K 1.35M – – – – 116.14M – – -847K
604K 42.34M 11.48M 111.98M 116K 862K – 601K 568K 17.25M 318.83M 4.76M 10.56M 130.52M 10.99M 2.05M 460K -50K 629K 116.14M 1.98M 820K -847K
-31.27M -2.12M 12.25M 11.69M -28.6M -63.81M -15.81M -38.2M -1.52M -86.53M 26.49M -26.57M 39.37M 157.74M 26.22M -55.95M -5.19M 37.51M -77.03M 62.01M -152.75M -16.12M -16.86M
-56.76M -70.05M -68.13M 27.92M -46.41M -43.44M -48.39M -46.81M -31.17M -30.59M -29.8M -25.2M -1.58M -22.87M -28.92M -23.31M -22.98M -21.97M -29.96M -26.93M -18.36M -16.94M -16.01M
-65.02M -75.94M -72.58M 22.37M -50.93M -48.4M -55.38M -54.39M -37.66M -36.67M -35.77M -31.11M -6.14M -27.84M -33.14M -27.65M -27.5M -26.29M -33.9M -30.66M -22.28M -20.76M -18.34M
-49K -55K – – 182K -53.84K -631K -910.08K -1.78M -349K -710K -549K – -701.03K -1.01M – -1.96M -2.07M -6.41M -4.29M -2.64M – -642K
– – – -631K -91K -12.16K – -38.92K – – – – -405K -103.97K – -1.09M – – – -808.07K – -737K –
-56.76M -70.05M -68.13M 28.55M -46.32M -43.43M -48.39M -46.77M -31.17M -30.59M -29.8M -25.2M -1.17M -22.77M -28.92M -22.21M -22.98M -21.97M -29.96M -26.12M -18.36M -16.21M -16.01M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.